cilomilast has been researched along with gsk 256066 in 2 studies
| Studies (cilomilast) | Trials (cilomilast) | Recent Studies (post-2010) (cilomilast) | Studies (gsk 256066) | Trials (gsk 256066) | Recent Studies (post-2010) (gsk 256066) |
|---|---|---|---|---|---|
| 162 | 13 | 42 | 15 | 0 | 13 |
| Protein | Taxonomy | cilomilast (IC50) | gsk 256066 (IC50) |
|---|---|---|---|
| cAMP-specific 3',5'-cyclic phosphodiesterase 4A | Homo sapiens (human) | 2.6333 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| He, J; Ke, H; Peng, T; Qi, B; Shi, J | 1 |
| He, Y; Hou, R; Hou, S; Liao, C; Xie, Z; Yan, G | 1 |
2 review(s) available for cilomilast and gsk 256066
| Article | Year |
|---|---|
Advances in the Development of Phosphodiesterase-4 Inhibitors.
Topics: Animals; Cyclic Nucleotide Phosphodiesterases, Type 4; Drug Development; Drug Discovery; Humans; Molecular Structure; Phosphodiesterase 4 Inhibitors; Protein Conformation; Quinolones; Vomiting | 2020 |
Zinc enzymes in medicinal chemistry.
Topics: Chemistry, Pharmaceutical; Enzyme Inhibitors; Enzymes; Humans; Models, Molecular; Zinc | 2021 |